Questions · Plain answers from studies
Your Thymosin Alpha-1 Questions, Answered
You’ll get a direct answer first. Then you’ll see what the studies can and can’t prove.
Does thymosin alpha 1 help with immune disease?
Goldstein’s group first asked how a thymus part guides immune cells. Later cell work found that Thymosin Alpha-1 could quiet an immune attack. One calming message has 10 in its lab name. The number is a name, not an amount [5].
People with psoriatic arthritis, lupus, or rheumatoid arthritis had lower blood levels of the compound [8]. A low level doesn’t show that taking more would help. These facts don’t prove a benefit for you.
What is thymosin alpha 1?
Goldstein and his coworkers found thymosin alpha-1 in calf thymus. They took the compound from a thymus mix called fraction 5. The number is only part of the mix’s name. In 1977, they mapped its 28-amino-acid chain, made of small protein building blocks [1].
The short chain is called a peptide. Your body cuts it from a larger protein. The count helps you tell similar compounds apart.
What does thymosin alpha 1 do?
Thymosin Alpha-1 can alert some immune cells and quiet others. First, the compound touches parts of cells that sense danger. Those cells then call in other immune cells to fight the threat [5].
The compound also starts a calming response. That response can keep the attack from going too far. For you, the main point is balance. You may not feel these cell changes.
What is thymosin alpha 1 used for?
Doctors abroad have used the compound to affect immune cells. The steadiest findings concern long-term hepatitis B. Studies also added it to care for melanoma, a skin cancer, as well as liver and lung cancer [7].
The compound wasn’t the main cancer drug in those studies. The findings don’t tell you that it treats cancer. The United States hasn’t approved it for sale [4].
Is thymosin alpha 1 FDA-approved?
No. Thymosin Alpha-1, also called thymalfasin, isn’t FDA-approved for sale in the United States. About 35 other countries have approved the drug for uses such as long-term hepatitis B [4].
In the US, some doctors have asked a pharmacy to make it for one patient. That is called compounding. Other use has been in research. Approval elsewhere doesn’t tell you whether the drug fits your health.
What is TA1 peptide?
TA1 peptide is another name for Thymosin Alpha-1. A peptide is a short protein chain. This one is a 28-amino-acid chain. An amino acid is a small protein building block. Goldstein’s team mapped it in 1977 [1].
Thymalfasin is the lab-made drug copy. You may see either name. They mean one compound.
Who needs care with thymosin alpha 1?
No page can tell you to take or avoid this drug. Three groups lack clear safety answers. People with an immune disease may face a concern because the compound can wake immune cells [8].
The compound may work against anti-rejection drugs after an organ transplant [5]. Pregnancy and breast-feeding also lack direct safety studies [4]. These are reasons for care, not proven harms. A doctor who knows your case can weigh them with you.
Is TB-500 the same as thymosin alpha 1?
No. TB-500 is a research name for thymosin beta-4. Its 43-amino-acid chain uses small protein building blocks and is tied to tissue repair. Thymosin Alpha-1 has a 28-amino-acid chain and affects immune cells [1]. That difference helps you keep the names apart.
One lab study found opposite effects. Alpha-1 helped one group of immune cells grow. Beta-4 let another group hold them back [9]. You can’t swap one name for the other.
How long was thymosin alpha 1 used in studies?
Study length depended on the illness. One review found repeated plans of 1.6–16 mg over five to seven days. Long-term hepatitis studies often used 1.6 mg twice weekly [4].
Sepsis trials lasted five to seven days [2][3]. One lung-cancer study gave weekly shots for up to 12 months. Those lengths tell you only what researchers did. You can’t use them to choose your own schedule.
How soon might thymosin alpha 1 work?
No study gives one start time for every person. After a shot, about half the compound left the blood in two hours. Doctors call that span the half-life. Blood levels moved near their starting point within about a day [4].
An immune-cell change isn’t like pain relief you feel at once. You can’t set a clock by it. Studies repeated shots because the compound left the blood soon.
What study plans used thymosin alpha 1?
Each study set its own dose plan. The plan changed with the illness. A large review found one-time doses from 0.8–6.4 mg. Long-term hepatitis studies often used 1.6 mg under the skin twice weekly [4].
Sepsis trials used 1.6 mg every 12 hours. That plan lasted five to seven days [2][3]. These are records of study care, not directions for you. The page doesn’t set your dose.
How might thymosin alpha 1 make you feel?
Many people say they didn’t feel anything unusual. That fits a compound that changes immune cells, not a feeling. The usual complaint is a red, itchy, or sore shot spot [4].
Some online posts mention steadier energy or fewer colds. No controlled study checked those claims. The reports can’t tell you how you’d feel. The effects page keeps those posts apart from study findings.
Can this site give me a thymosin alpha 1 dose?
This page can’t give you a personal dose. Studies tested one-time doses from 0.8 to 6.4 mg. Long-term hepatitis studies often used 1.6 mg under the skin twice weekly [4].
Those amounts belonged to set groups of patients. They aren’t a safe starting point for you. The United States hasn’t approved this use [4]. A doctor would need to weigh your own health.
Did studies find a best time for thymosin alpha 1?
Researchers haven’t found one best time of day. They only set how often each study group got a shot. Long-term hepatitis studies used 1.6 mg twice weekly. Sepsis studies used shots every 12 hours [4][3].
Those plans match the compound’s short stay in blood. They don’t tell you when to take it. You won’t find a personal schedule here.
What do studies say about thymosin alpha 1 safety?
Studies abroad found mostly mild side effects. Redness, itching, or soreness at the shot spot came up most. Large checks after sale found no organ harm at studied doses [4].
Those facts don’t answer every risk for you. A vial sold for research may be weak, mislabeled, or unclean [4]. Your immune disease or organ transplant may also raise concerns [5]. The compound isn’t FDA-approved in the US.
Does thymosin alpha 1 help cancer?
Researchers added Thymosin Alpha-1 to other cancer care. They didn’t study the compound as the only treatment. Papers cover melanoma, a skin cancer, as well as liver and lung cancer [7].
Some papers say the compound may help immune cells spot a tumor. It may also ease harm from some cancer drugs. These findings came from reviews and combined care. They can’t tell you that the compound helps cancer.
Is thymosin alpha 1 worth it?
Only you and a doctor can weigh that choice. The clearest support comes from long-term hepatitis B [14]. COVID-19 findings don’t agree. In the biggest sepsis trial, people who got the compound didn’t live longer [3].
The United States hasn’t approved the compound for sale [4]. The human findings are real, but uneven. They can’t give you a sure answer.
Does thymosin affect aging?
Blood levels of Thymosin Alpha-1 fall as people get older. The immune system also tends to weaken with age. Those changes led researchers to test the compound as added help with vaccines [4].
No study here shows that the compound slows aging. The work doesn’t show that you would live longer or feel younger. It only links the research to immune change with age.
Did thymosin alpha 1 cut deaths from severe COVID-19?
The first report looked back at records from 76 very sick patients. Care wasn’t assigned by chance. Deaths were 11.11% with the compound and 30.00% without it [6]. The gap looks hopeful, but this kind of report can’t prove the cause.
A 2022 review then joined roughly 5,300 patients. It found no clear drop in deaths. You can’t treat the first report as proof. Survival benefit remains unsettled.
What do people report after thymosin alpha 1 research use?
People using the compound for research have posted personal accounts. Some mention fewer colds or steadier energy after a long illness. No controlled study tested those claims. The reports aren’t trial findings.
The effects page keeps the accounts apart from study results. They can’t predict what you would feel. The human findings came from planned studies, not these posts.
How is thymosin alpha 1 vs thymosin beta 4 (TB-500) different?
Thymosin Alpha-1 has a 28-amino-acid chain made of small protein building blocks and affects immune cells. Thymosin beta-4, called “TB-500” in research sales, has a 43-amino-acid chain tied to tissue repair [1]. The part counts help you compare the chains. Those different roles help you keep the compounds apart.
A lab test mixed human immune cells. Alpha-1 helped one group grow. Beta-4 let another group hold them back [9]. You can’t treat the two names as one compound.
What dose of thymosin alpha 1 did studies use?
This page doesn’t report what private users take. Trials often used 1.6 mg under the skin twice weekly. A large review found one-time doses from 0.8–6.4 mg [4].
Those amounts came from set groups of patients. They aren’t a guide for your use. The United States hasn’t approved the compound for sale [4]. A forum dose can’t tell you what is safe.